These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23137509)

  • 21. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
    Ripa RS
    Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction.
    Beeres SL; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2007 Oct; 100(7):1094-8. PubMed ID: 17884369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).
    Tse HF; Thambar S; Kwong YL; Rowlings P; Bellamy G; McCrohon J; Thomas P; Bastian B; Chan JK; Lo G; Ho CL; Chan WS; Kwong RY; Parker A; Hauser TH; Chan J; Fong DY; Lau CP
    Eur Heart J; 2007 Dec; 28(24):2998-3005. PubMed ID: 17984132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
    Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Carvalho AC; Dutra HS; Dohmann HJ; Silva GV; Belém L; Vivacqua R; Rangel FO; Esporcatte R; Geng YJ; Vaughn WK; Assad JA; Mesquita ET; Willerson JT
    Circulation; 2003 May; 107(18):2294-302. PubMed ID: 12707230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery.
    Zhao Q; Sun Y; Xia L; Chen A; Wang Z
    Ann Thorac Surg; 2008 Dec; 86(6):1833-40. PubMed ID: 19021989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
    Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Silva GV; Mesquita CT; Belém L; Vaughn WK; Rangel FO; Assad JA; Carvalho AC; Branco RV; Rossi MI; Dohmann HJ; Willerson JT
    Circulation; 2004 Sep; 110(11 Suppl 1):II213-8. PubMed ID: 15364865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
    Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
    EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study.
    Lipiec P; Krzemińska-Pakuła M; Plewka M; Kuśmierek J; Płachcińska A; Szumiński R; Robak T; Korycka A; Kasprzak JD
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):587-93. PubMed ID: 19050877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of intramyocardial injection of autologous bone marrow cells to treat myocardial ischemia in pigs.
    Goodchild T; Pang W; Tondato F; Cui J; Otsuka Y; Frowein S; Ungs M; Robinson K; Poznansky M; Chronos N
    Cardiovasc Revasc Med; 2006; 7(3):136-45. PubMed ID: 16945820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
    Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD
    Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.
    Ripa RS; Wang Y; Jørgensen E; Johnsen HE; Hesse B; Kastrup J
    Eur Heart J; 2006 Aug; 27(15):1785-92. PubMed ID: 16825290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function.
    van Ramshorst J; Antoni ML; Beeres SL; Roes SD; Delgado V; Rodrigo SF; de Roos A; Holman ER; Fibbe WE; Lamb HJ; Zwaginga JJ; Boersma E; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):122-9. PubMed ID: 21209073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain.
    van Ramshorst J; Atsma DE; Beeres SL; Mollema SA; Ajmone Marsan N; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Heart; 2009 Feb; 95(2):119-24. PubMed ID: 18198204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
    Kastrup J; Jørgensen E; Rück A; Tägil K; Glogar D; Ruzyllo W; Bøtker HE; Dudek D; Drvota V; Hesse B; Thuesen L; Blomberg P; Gyöngyösi M; Sylvén C;
    J Am Coll Cardiol; 2005 Apr; 45(7):982-8. PubMed ID: 15808751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.
    Perin EC; Silva GV; Zheng Y; Gahremanpour A; Canales J; Patel D; Fernandes MR; Keller LH; Quan X; Coulter SA; Moore WH; Herlihy JP; Willerson JT
    Am Heart J; 2012 Mar; 163(3):415-21, 421.e1. PubMed ID: 22424012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
    Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
    Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
    Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
    J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.